Global market for autacoids and related drugs to be worth $112.6 billion by 2015

Global sales of autacoids and related drugs in 2008 were $95.1 billion, which declined to $94.6 billion in 2009. However, the market is expected to rise at a compound annual growth rate (CAGR) of 3.2% to reach $112.6 billion by 2015.
Learn about the present and future strategies within the autacoids and related drug market, including the biogenic amines, polypeptide derivatives, lipid-derived autacoids, and endothelium-derived autacoids...

Use this report to:

• Receive comprehensive analysis of the current market for autacoids and related drugs and its future direction, while examining the x biologic activity and usage of autacoids in the treatment of various diseases.
• Understand the present and future strategies within the autacoids and related drug market, including the biogenic amines, polypeptide derivatives, lipid-derived autacoids, and endothelium-derived autacoids.
• See 5-year forecasts and trends based on detailed analysis of the structure of commerce in autacoids and related products, including all four major categories of autacoid-related products, further divided into subcategories and revenues broken down by region and subcategories from 2010 through 2015.
• Determine the applications for autacoids and related products utilizing their therapeutic benefits, with emphasis on results in respiratory, cardiovascular, CNS, analgesics, and antiemetics.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.